Lawrence Biegelsen
Stock Analyst at Wells Fargo
(0.86)
# 3,642
Out of 5,182 analysts
60
Total ratings
42.11%
Success rate
-10.68%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lawrence Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Maintains: Equal-Weight | $157 → $161 | $149.43 | +7.74% | 7 | May 8, 2026 | |
| PODD Insulet | Maintains: Overweight | $360 → $255 | $154.16 | +65.41% | 7 | May 7, 2026 | |
| ABT Abbott Laboratories | Maintains: Overweight | $142 → $146 | $84.32 | +73.15% | 9 | Oct 16, 2025 | |
| NPCE NeuroPace | Upgrades: Overweight | $16 → $20 | $18.35 | +8.99% | 7 | Mar 14, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $166 → $82 | $15.48 | +429.72% | 5 | Aug 4, 2022 | |
| TFX Teleflex | Downgrades: Equal-Weight | $248 | $133.06 | +86.38% | 1 | Jul 29, 2022 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $350 → $339 | $450.06 | -24.68% | 2 | Apr 22, 2022 | |
| REE REE Automotive | Initiates: Underweight | $1.5 | $0.47 | +217.53% | 1 | Mar 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $55 → $27 | $1.26 | +2,042.86% | 3 | Feb 24, 2022 | |
| ZBH Zimmer Biomet Holdings | Maintains: Underweight | $124 → $111 | $82.33 | +34.82% | 2 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $144 | $60.61 | +137.17% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $56 | $133.52 | -58.06% | 4 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $68 → $74 | $61.27 | +20.78% | 6 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $77 | $79.96 | -4.11% | 3 | Apr 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $85 → $90 | $17.89 | +403.07% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $77.95 | - | 1 | Dec 12, 2019 |
Becton, Dickinson and Company
May 8, 2026
Maintains: Equal-Weight
Price Target: $157 → $161
Current: $149.43
Upside: +7.74%
Insulet
May 7, 2026
Maintains: Overweight
Price Target: $360 → $255
Current: $154.16
Upside: +65.41%
Abbott Laboratories
Oct 16, 2025
Maintains: Overweight
Price Target: $142 → $146
Current: $84.32
Upside: +73.15%
NeuroPace
Mar 14, 2024
Upgrades: Overweight
Price Target: $16 → $20
Current: $18.35
Upside: +8.99%
Tandem Diabetes Care
Aug 4, 2022
Maintains: Overweight
Price Target: $166 → $82
Current: $15.48
Upside: +429.72%
Teleflex
Jul 29, 2022
Downgrades: Equal-Weight
Price Target: $248
Current: $133.06
Upside: +86.38%
Intuitive Surgical
Apr 22, 2022
Maintains: Overweight
Price Target: $350 → $339
Current: $450.06
Upside: -24.68%
REE Automotive
Mar 25, 2022
Initiates: Underweight
Price Target: $1.5
Current: $0.47
Upside: +217.53%
Pulmonx
Feb 24, 2022
Maintains: Equal-Weight
Price Target: $55 → $27
Current: $1.26
Upside: +2,042.86%
Zimmer Biomet Holdings
Feb 8, 2022
Maintains: Underweight
Price Target: $124 → $111
Current: $82.33
Upside: +34.82%
Jan 19, 2022
Upgrades: Overweight
Price Target: $144
Current: $60.61
Upside: +137.17%
Jan 19, 2022
Upgrades: Equal-Weight
Price Target: $56
Current: $133.52
Upside: -58.06%
Oct 29, 2021
Maintains: Equal-Weight
Price Target: $68 → $74
Current: $61.27
Upside: +20.78%
Apr 28, 2020
Downgrades: Equal-Weight
Price Target: $77
Current: $79.96
Upside: -4.11%
Mar 5, 2020
Upgrades: Overweight
Price Target: $85 → $90
Current: $17.89
Upside: +403.07%
Dec 12, 2019
Upgrades: Overweight
Price Target: n/a
Current: $77.95
Upside: -